Localization of hidden insulinomas with 68Ga-DOTA-Exendin-4 PET/CT: A pilot study

Journal of Nuclear Medicine

Volumn 56, Issue 7, 2015, Pages 1075-1078

  Antwi, Kwadwo ^a   Fani, Melpomeni ^a   Nicolas, Guillaume ^a   Rottenburger, Christof ^a   Heye, Tobias ^a   Claude Reubi, Jean ^b   Gloor, Beat ^c   Christ, Emanuel ^c   Wild, Damian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

68Ga; Exendin 4; Glucagon like peptide 1 receptor targeting; Insulinoma

Indexed keywords

EXENDIN 4 TETRAXETAN GA 68; EXENDIN 4 TETRAXETAN IN 111; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 1,4,7,10-TETRAAZACYCLODODECANE- 1,4,7,10-TETRAACETIC ACID; EXENDIN 4; GALLIUM; GLUCOSE; PEPTIDE; SINGLE HETEROCYCLIC RINGS; VENOM;

ADULT; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSSOVER PROCEDURE; CT-SPECT SCANNER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOGENOUS HYPERINSULINEMIC HYPOGLYCEMIA; FEASIBILITY STUDY; FEMALE; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; INSULINOMA; INTERMETHOD COMPARISON; MALE; MIDDLE AGED; MULTICENTER STUDY; NAUSEA; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS RESECTION; PET-CT SCANNER; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR LOCALIZATION; CHEMISTRY; DIAGNOSTIC IMAGING; IMMUNOHISTOCHEMISTRY; MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; WHOLE BODY IMAGING;

ADULT; CROSS-OVER STUDIES; DIAGNOSTIC IMAGING; FEMALE; GALLIUM RADIOISOTOPES; GLUCOSE; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; IMMUNOHISTOCHEMISTRY; INSULINOMA; MALE; MIDDLE AGED; MULTIMODAL IMAGING; PEPTIDES; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; VENOMS; WHOLE BODY IMAGING;

EID: 84936802430     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.115.157768     Document Type: Article

References (10)

1. de Herder WW, Niederle B, Scoazec J-Y, et al. Well-differentiated pancreatic tumor/carcinoma: insulinoma. Neuroendocrinology. 2006;84:183-188.
2. Christ E, Wild D, Ederer S, et al. Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: A prospective multicentre imaging study. Lancet Diabetes Endocrinol. 2013;1:115-122.
3. Christ E, Wild D, Forrer F, et al. Glucagon-like peptide-1 receptor imaging for localization of insulinomas. J Clin Endocrinol Metab. 2009;94:4398-4405.
4. Sowa-Staszczak A, Pach D, Mikołajczak R, et al. Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC-99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma. Eur J Nucl Med Mol Imaging. 2013;40:524-531.
5. Martin WH, Delbeke D, Patton JA, Sandler MP. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose. Radiology. 1996;198:225-231.
6. Eriksson O, Velikyan I, Selvaraju RK, et al. Detection of metastatic insulinoma by positron emission tomography with [68Ga]exendin-4: A case report. J Clin Endocrinol Metab. 2014;99:1519-1524.
7. Wild D, Wicki A, Mansi R, et al. Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CTand SPECT/CT. J Nucl Med. 2010;51:1059-1067.
8. Körner M, Stöckli M, Waser B, Reubi JC. GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J Nucl Med. 2007;48:736-743.
9. Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48:932-945.
10. Druce MR, Muthuppalaniappan VM, O'Leary B, et al. Diagnosis and localisation of insulinoma: The value of modern magnetic resonance imaging in conjunction with calcium stimulation catheterisation. Eur J Endocrinol. 2010;162:971-978.